BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.80
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
8.97
+0.17 (1.93%)
After-hours: Apr 28, 2026, 6:08 PM EDT

BBOT Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for BBOT stock have an average target of 24, with a low estimate of 20 and a high estimate of 29. The average target predicts an increase of 172.73% from the current stock price of 8.80.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $20 $24 $24 $29
Change +127.27% +172.73% +172.73% +229.55%
* Price targets were last updated on Mar 6, 2026.

Analyst Ratings

The average analyst rating for BBOT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 111222
Buy 345555
Hold 000000
Sell 000000
Strong Sell 000000
Total 456777

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$27$29
Strong Buy Maintains $27$29 +229.55% Mar 6, 2026
Stifel
Stifel
Strong Buy
Initiates
$23
Strong Buy Initiates $23 +161.36% Feb 11, 2026
Raymond James
Raymond James
Buy
Initiates
$24
Buy Initiates $24 +172.73% Jan 9, 2026
Wedbush
Wedbush
Buy
Reiterates
$25
Buy Reiterates $25 +184.09% Dec 11, 2025
Morgan Stanley
Morgan Stanley
Buy
Initiates
$20
Buy Initiates $20 +127.27% Dec 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.26
from -4.30
EPS Next Year
-2.22
from -2.26
Fiscal Year FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
-------
Revenue Growth
-------
EPS
-518.73-5,756.41-4.30-2.26-2.22-2.13-2.00
EPS Growth
-------
Forward PE
-------
No. Analysts ---1110106
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030203120322033
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -

EPS Forecast

EPS 20262027202820292030203120322033
High -1.96 -1.87
Avg -2.26 -2.22
Low -2.56 -2.53

EPS Growth

EPS Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.